Steinback CD, Salzer D, Medeiros PJ, Kowalchuk J, Shoemaker JK. Hypercapnic vs. hypoxic control of cardiovascular, cardiovagal, and sympathetic function. We compared the integrated cardiovascular and autonomic responses to hypercapnia and hypoxia to test the hypothesis that these stimuli differentially affect muscle sympathetic nerve activity (MSNA) discharge patterns and cardiovagal and sympathetic baroreflex function in a manner related to ventilatory chemoreflex sensitivity. Six males and six females underwent 5 min of hypoxia (end-tidal PO2 ϭ 45 Torr) and 5 min of hypercapnia (end-tidal PCO2 ϭ ϩ8 Torr from baseline), causing similar ventilatory responses. A downward right shift in cardiovagal set point was observed during both conditions, which was strongly related to the change in inspiratory time (Ti) from baseline to hypercapnia (r 2 ϭ 0.67, P ϭ 0.007) and hypoxia (r 2 ϭ 0.79, P Ͻ 0.001). Cardiovagal baroreflex gain was decreased during hypoxia (20.1 Ϯ 6.9 vs. 8.9 Ϯ 5.1 ms/mmHg, P Ͻ 0.001) but not hypercapnia (26.7 Ϯ 12.7 vs. 23.0 Ϯ 9.1 ms/mmHg). Both hypoxia and hypercapnia increased MSNA burst amplitude, whereas hypoxia, but not hypercapnia, also increased in MSNA burst frequency (21 Ϯ 9 vs. 28 Ϯ 7 bursts/min, P ϭ 0.03) and total MSNA (4.56 Ϯ 3.07 vs. 7.37 Ϯ 3.26 mV/min, P ϭ 0.002). However, neither hypercapnia nor hypoxia affected sympathetic burst probability or baroreflex gain. Hypoxia also caused a greater reduction in total peripheral resistance (P ϭ 0.04), a greater increase in heart rate (P ϭ 0.002), and a trend for a greater cardiac output response (P ϭ 0.06) compared with hypercapnia. Nonetheless, central venous pressure remained unchanged during either condition. These results suggest that hypercapnia and hypoxia exert differential effects on cardiovagal, but not sympathetic, baroreflex gain and set point in a manner not related to ventilatory chemoreflex sensitivity. Furthermore, the data suggest that the individual's respiratory pattern to hypoxia or hypercapnia, as reflected in the inspiratory time, was a strong determinant of cardiovagal baroreflex setpoint rather than the total ventilatory chemoreflex gain per se. respiration; autonomic nervous system; sympathetic nerve activity; baroreflex Address for reprint requests and other correspondence:
ELEVATED LEVELS OF CARBON dioxide (hypercapnia) and/or decreased levels of oxygen (hypoxia) in the blood are detected by chemoreceptors that act through neural networks to influence ventilatory and cardiovascular function. While chemoreflexinduced sympathetic activation is expected to exert a vasoconstrictive influence under these conditions, there is a concurrent dilatory effect of hypercapnia and hypoxia (39) . Additionally, cardiac output is maintained or increased, depending on the severity of the stimulus (39, 46) . This elevation in cardiac output is not due solely to reduced afterload, as it requires an intact sympathetic nervous system (4) . Also, acutely changing the background inspired air from a hypoxic to hyperoxic mixture causes a rightward shift in the threshold for ventilatory, sympathetic, and cardiac output responses during a CO 2 rebreathe test (46) , providing further evidence of a strong integration of ventilatory, autonomic, and cardiovascular responses to chemoreflex activation.
Many features of the integrated ventilatory, autonomic, and cardiovascular response to chemoreflex activation are not understood. For example, it is unclear whether systemic hypercapnia and hypoxia exert differential effects on the coordinated ventilatory, autonomic, and cardiovascular control. Somers et al. (49) documented greater total muscle sympathetic nerve activity (MSNA) during hypercapnia, compared with hypoxia at a comparable isoventilatory point, although peak ventilatory stimulation remained different between conditions. In contrast, Narkiewicz et al. (25) observed a higher MSNA response to hypoxia, compared with hypercapnia in participants with slow and fast spontaneous breathing rates. Though not by design, this stratification of their participants resulted in groups with comparable ventilatory responses. Others (58) have shown a persistent augmentation of MSNA frequency during the recovery phase following hypoxia but not hypercapnia, whereas Tamisier et al. (53) documented a similar persistence in MSNA following hypercapnic hypoxia but not hypocapnic hypoxia. Furthermore, Teppema et al. (55) documented different patterns of c-fos expression in nuclei within the caudal ventrolateral medulla (A1 region), rostral ventrolateral medulla (C1 region), and A5 regions of the rat brain stem during hypercapnia (15% CO 2 ) and hypoxia (9% O 2 ). While the authors were unable to distinguish between chemoreflex, respiratory, or cardiovascularinduced activation, their data suggest that hypercapnia and hypoxia cause distinct patterns of activation within regions normally associated with sympathetic control. Differences among these studies may be related to variations in the duration or magnitude (40) of chemoreflex stimulation and/or the associated ventilatory response to the hypoxia or hypercapnia.
First, the increase in ventilation during both hypoxia and hypercapnia may also exert important neural and mechanical (i.e., the respiratory pump mechanism) effects on cardiovascular and autonomic function in a manner that varies with posture and ventilatory pattern (14, 15, 38, 44) . To date, no study has compared the effects of systemic hypercapnia and hypoxia on cardiovascular and autonomic function while controlling the magnitude of chemostimulation and the influence of the ventilatory responses.
Second, the mechanism(s) supporting an elevated cardiac output during chemoreflex activation in the face of vasodilation has not been identified in humans. However, early studies in anesthetized animals suggest that hypercapnic chemoreflex activation, or a direct vascular effect of carbon dioxide, reduces venous distensibility within the visceral regions (e.g., splanchnic, mesenteric, splenic), reducing blood transit time to enhance venous return and right atrial pressure (28, 29, 37) . Stated differently, it may be that the sympathetic response to chemoreflex activation mobilizes blood back to the heart, sustaining central filling pressures.
Third, it is not known whether individual variations in ventilatory chemoreflex sensitivity are associated with altered autonomic or cardiovascular control. In clinical settings, an enhanced ventilatory response to chemoreflex activation is strongly associated with heightened sympathetic activation (24) .
Finally, hypoxia and hypercapnia may exert differential cardiovascular and autonomic control through interactions with the baroreflex. The architecture of the autonomic nervous system has both baroreceptor and chemoreceptor pathways overlapping within the nucleus tractus solitarius, nucleus ambiguous, and caudal and rostral ventrolateral medulla, among other regions of the brain stem (9) , regions that regulate sympathetic and parasympathetic cardiovascular function. The early work of Bristow et al. (6, 7) and Cunningham et al. (8) provided experimental evidence in humans of cardiovagal baroreflex resetting by chemoreflex stimulation and is supported by more recent findings (18, 19, 36, 41) . However, uncertainty still exists regarding the impact of hypercapnia and hypoxia on cardiovagal baroreflex gain. Investigations have variably shown no change in gain in response to hypercapnia (6, 47) or hypoxia (19) , a depressed gain in response to hypercapnia (7, 8) and hypoxia (18, 36) , or an augmented gain in response to hypoxia (16) . In more recent studies of the sympathetic baroreflex, Simmons et al. (47) showed no impact of hypercapnia on sympathetic baroreflex set point or gain, while Halliwill and colleagues (18, 19) documented a resetting, but no change in gain, in response to hypoxia. Thus, hypercapnia and hypoxia may exert stimulus-specific effects on sympathetic baroreflex control. However, to our knowledge, no study has examined the different impact of hypercapnia and hypoxia on the sympathetic baroreflex in the same study.
Therefore, the primary purpose of this study was to compare the influence of hypercapnia and hypoxia on cardiovascular and autonomic function when the magnitude of chemostimulation was maintained in each stimulus. We tested the hypothesis that hypercapnia and hypoxia differentially affect cardiovagal and sympathetic baroreflex function, as well as sympathetic discharge patterns, in a manner that is related to ventilatory chemoreflex sensitivity. In addition, we aimed to establish the integrated relationships between cardiac output, venous return, sympathetic activation, and discharge properties, as well as peripheral vascular resistance during hypercapnic and hypoxic stimulation.
METHODS

Subjects.
Twelve healthy subjects (6 male and 6 female) aged 26 Ϯ 4 yr (mean Ϯ SD; range, 21-35 yr) participated after receiving verbal and written instructions outlining the experimental procedures and providing informed written consent. Female participants were taking oral contraceptives, and all subjects reported taking no other medications. All participants were nonsmokers, and none had any history of cardiovascular or respiratory disease. This study was approved by the Health Sciences Research Ethics Board at The University of Western Ontario.
Experimental setup. Subjects abstained from caffeine, alcohol, and strenuous activity for at least 12 h before testing. During all testing, participants were supine and breathed through a facemask that allowed normal mouth and/or nasal breathing (Hans Rudolph). To ensure an airtight seal while maintaining subject comfort, the facemask was secured to the subject's face using adhesive tape (Tagederm 1626W; 3M Health Sciences, Canada).
Protocol. During experimentation, participants performed two protocols separated by a 30-min rest period. The first protocol began with 10 min of quiet baseline, followed by a step increase in the partial pressure of end-tidal CO 2 (PETCO 2 ) to ϩ8 Torr above the participant's resting PET CO 2 , while the partial pressure of end-tidal O2 (PETO 2 ) was held constant. This level of isooxic hypercapnia was then maintained for 5 min. The second protocol consisted of a similar 10-min baseline period, which was then followed by a step decrease in PET O 2 to 45 Torr, while PET CO 2 was held constant. This level of isocapnic hypoxia was maintained for 5 min. Delivered gases were humidified using custom-built humidification tanks.
Step changes in end-tidal gases were achieved within 2-3 breaths and accurately maintained thereafter using the technique of dynamic end-tidal forcing (34, 35) . The protocols were not assigned randomly because hypoxia, but not hypercapnia, produces long-lasting autonomic responses (58) . The levels of hypercapnia and hypoxia were chosen based on normative data from the literature (see Refs. 50 and 32) and designed to produce similar ventilatory responses.
Data acquisition. Mean arterial pressure, systolic blood pressure, and diastolic blood pressure were calculated on a beat-by-beat basis from the blood pressure waveform using finger photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The Netherlands). R-R interval and heart rate were calculated from a standard three-lead ECG. Cardiac output was determined by the Modelflow method (57) , and total peripheral resistance was calculated as mean arterial pressure/cardiac output. A venous catheter was inserted into the median or cephalic vein of the right arm to measure peripheral venous pressure, an index of central venous pressure (2) , as well as to allow for periodic blood draws. Blood samples were subsequently analyzed for circulating levels of epinephrine and norepinephrine by HPLC.
MSNA was assessed in the right fibular (peroneal) nerve by microneurography (17) . A tungsten microelectrode (35 mm long, 200 m in diameter, and tapered to a 1-to 5-m uninsulated tip) was inserted transcutaneously into the fibular nerve posterior to the fibular head. A reference electrode was positioned subcutaneously 1-3 cm from the recording site. An MSNA site was confirmed by manually manipulating the microelectrode until a characteristic pulse-synchronous burst pattern was observed that did not produce skin paresthesias and that increased in response to voluntary apnea but not during arousal to a loud noise (13) . MSNA activity was amplified ϫ1,000 through a preamplifier and ϫ75 by a variable-gain, isolated amplifier. The amplified, raw MSNA signal was band-pass filtered at a bandwidth of 700 -2,000 Hz and then rectified and integrated to obtain a mean voltage neurogram (0.1-s time constant) (model 662C-3; Iowa University Bioengineering). Raw and integrated MSNA (and cardiovascular) data were sampled at 10,000 Hz and stored for off-line analysis (Powerlab Software, ADInstruments).
At the beginning of the experimental session each subject's resting PETCO 2 and PETO 2 were measured for ϳ10 min. Respired gas was sampled continuously (20 ml/min) via a small-bore catheter (0.3-mm internal diameter) and analyzed for PO2 and PCO2 by mass spectrometer (model AMIS 2000; Innovision, Denmark). Values for PETCO 2 and PETO 2 were identified and recorded for each breath using a computer and dedicated software (University Laboratory of Physiol-ogy, Oxford, UK). Respiratory volumes were measured using a turbine device (model VMM-2A; Interface Associates), while flow direction and timing were determined using a pneumotachograph (model 4813; Hans Rudolph) and differential pressure transducer (CD-12, Validyne). Breath-by-breath minute ventilation (V E), tidal volume (Vt), breathing frequency (f B), and inspiratory time (Ti) were determined from the ventilatory record by the collection software and stored for off-line analysis.
Data analysis. Cardiovascular and respiratory data were averaged over 1-min bins during baseline and after ϳ3 min of hypercapnic or hypoxic breathing. The gain of the ventilatory and cardiovascular responses to acute hypercapnia were calculated as the relationship between ⌬response/⌬PET CO 2 . The ventilatory and cardiovascular responses to acute isocapnic hypoxia were characterized by linearizing PET O 2 to a calculation of hemoglobin saturation (45) .
MSNA bursts were identified as exhibiting pulse synchrony, having an amplitude two times the previous interburst period and having characteristic rising and falling slopes. Burst occurrence was confirmed by visually inspecting the corresponding raw neurogram. MSNA was measured as amplitude/burst (mV), burst frequency (burst/min), total MSNA (mV/min), and burst incidence (bursts/100 heart beats). To properly assess MSNA and the sympathetic baroreflex, MSNA data were averaged over the 4 min immediately preceding hypercapnia or hypoxia (baseline) and the final 4 min of hypercapnia or hypoxia.
The spontaneous cardiovagal baroreflex control was determined using the sequence method (5, 27, 48) . Briefly, regression analyses were performed on sequences of three or more consecutive cardiac cycles exhibiting concurrent changes in systolic blood pressure and R-R interval (both rising or both falling). Secondary analysis was performed on the same data to assess sequences with concurrent changes in systolic blood pressure and heart rate (both changing in opposite directions). The analysis was performed on ϳ240 cardiac cycles at rest and ϳ300 cardiac cycles during hypercapnia and hypoxia, resulting in 35 Ϯ 12 and 44 Ϯ 16 baroreflex sequences for analysis, respectively. On the basis of evidence that the R-R interval is generally modulated within the same cardiac cycle (30), we analyzed 10 of 11 data sets using a lag 0 criterion (5). However, one data set was analyzed using a lag 1 approach to increase the number of sequences. The mean slope of identified sequences was taken to represent cardiovagal baroreflex gain. Only regressions with an r 2 Ͼ 0.85 were included in the analysis. The cardiovagal set point was determined as the quotient of the prevailing R-R interval and systolic blood pressure in each state of baseline and reflex activation.
The impact of hypoxia and hypercapnia on the baroreflex control of MSNA was assessed by relating burst probability to corresponding diastolic blood pressure values (52) . The slope of this relationship was taken to represent spontaneous sympathetic baroreflex sensitivity (52) .
Statistical analysis. The separate effects of hypoxia and hypercapnia on each variable were assessed using paired, two-tailed t-tests. To compare the impact of hypoxia against hypercapnia in the two groups (that contained somewhat different individuals), the change in response from baseline (⌬) was compared using t-tests for independent groups (Statistical Analysis System 9.1). To account for multiple comparisons (c), P values were corrected using the chosen comparison-wise error rate (␣, 0.05) and the calculated experiment-wise error rate (␣ e) (20) :
where, P 0 and P 1 represent the original and corrected P values, respectively, and ␣ 1 represents the adjustment factor based on the chosen level of significance. Relationships among Vt, Ti, and cardiovagal set point were assessed using Pearson correlations. With all analyses, the probability level was P 1 Ͻ 0.05. Data are expressed as means Ϯ SD.
RESULTS
Of the 12 participants in the present study, 10 completed the hypercapnia protocol, and 11 completed the hypoxia protocol (9 participants completed both protocols). Furthermore, MSNA data were obtained in 6 of 10 subjects during hypercapnia and 7 of 11 subjects during hypoxia (4 participants produced sets of MSNA data during both hypercapnia and hypoxia). As a result, ventilatory, cardiovascular, and sympathetic data were analyzed using separate approaches. A repeated-measures subanalysis of the four subjects in whom MSNA was obtained during both protocols was also performed.
Data at rest and during hypercapnia and hypoxia are shown in Table 1 . Compared with baseline, PET CO 2 was elevated by Values expressed as means Ϯ SD. PETCO 2 , partial pressure of end-tidal CO2; PETO 2 , partial pressure of end-tidal O2; V E, minute ventilation; Vt, tidal volume; fB, breathing frequency; Ti, inspiratory time, MAP, mean arterial pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; PVP, peripheral venous pressure; TPR, total peripheral resistance; NE, norepinepherine; EPI, epinepherine; MSNA, muscle sympathetic nerve activity. Significant difference compared to baseline: *P Ͻ 0.05, †P Ͻ 0.01, ‡P Ͻ 0.001. 9.6 Ϯ 1.6 Torr from baseline (P Ͻ 0.001), while during hypoxia, PET O 2 was reduced to 44 Ϯ 2 Torr (81 Ϯ 2.2%, arterial hemoglobin saturation) (P Ͻ 0.001). Both hypercapnia and hypoxia resulted in similar increases in ventilation (ϩ17.4 Ϯ 5.0 l/min and ϩ19.2 Ϯ 10.5 l/min, respectively). The hypoxic and hypercapnic ventilatory responses were 1.09 Ϯ 0.58 l⅐min Ϫ1 ⅐%desaturation Ϫ1 (range, 0.30 -2.44⅐min Ϫ1 ⅐%desaturation Ϫ1 ) and 1.86 Ϯ 0.68 l⅐min Ϫ1 ⅐Torr Ϫ1 (range, 0.93-2.76 l⅐min Ϫ1 ⅐Torr Ϫ1 ), respectively. Inspiratory drive as determined by mean inspiratory flow (VT/Ti) was not different during hypoxia (1.03 Ϯ 0.39 l/ms) and hypercapnia (0.91 Ϯ 0.16 l/ms).
Both hypercapnia and hypoxia produced similar elevations in mean arterial pressure; 94 Ϯ 7 to 103 Ϯ 9 mmHg during hypercapnia (P Ͻ 0.001) and 94 Ϯ 8 to 99 Ϯ 10 mmHg (P ϭ 0.012) during hypoxia. The gain of the mean arterial pressure response was 0.94 Ϯ 0.55 mmHg/Torr (range, 0.33-1.97 mmHg/Torr) during hypercapnia and 0.28 Ϯ 0.34 mmHg/ %desaturation (range, Ϫ0.23-1.07 mmHg/%desaturation) during hypoxia. Similarly, systolic blood pressure was increased during hypoxia (127 Ϯ 11 to 136 Ϯ 10 mmHg; P Ͻ 0.001) and hypercapnia (127 Ϯ 7 to 139 Ϯ 10 mmHg; P Ͻ 0.001). Hypoxia caused a greater increase in heart rate (ϩ21 Ϯ 9 beats/min) compared with hypercapnia (ϩ11 Ϯ 8 beats/min) (P ϭ 0.002). The gain of the heart rate response was 1.12 Ϯ 0.63 (beats/min)/Torr [range, 0.10 -2.37 (beats/min)/Torr] during hypercapnia and 1.16 -0.49 (beats/min)/%desaturation [range, 0.62-1.99 (beats/min)/%desaturation]. There was a trend for a larger increase in cardiac output (ϩ1.72 Ϯ 0.78) in hypoxia compared with hypercapnia (ϩ1.13 Ϯ 0.80; P ϭ 0.06), whereas total peripheral resistance was reduced more during hypoxia (Ϫ3.97 Ϯ 1.56 mmHg⅐ l Ϫ1 ⅐min Ϫ1 ) compared with hypercapnia (Ϫ1.81 Ϯ 1.82 mmHg⅐l Ϫ1 ⅐min Ϫ1 ) (P ϭ 0.04). peripheral venous pressure was unaffected by either hypoxia or hypercapnia. Neither hypoxia nor hypercapnia affected circulating norepinephrine, whereas epinephrine was increased similarly during both hypercapnia (P ϭ 0.04) and hypoxia (P ϭ 0.03) ( Table 1) .
Analysis of spontaneous cardiovagal baroreflex control indicated no change from baseline in slope (26.7 Ϯ 12.7 vs. 23.0 Ϯ 9.1 ms/mmHg) or intercept (Ϫ2,469 Ϯ 1,551 vs. Ϫ2,330 Ϯ 1,135 ms) during hypercapnia. However, cardiovagal baroreflex slope was decreased (20.1 Ϯ 6.9 vs. 8.9 Ϯ 5.1 ms/mmHg, P Ͻ 0.001), and the intercept increased (Ϫ1,760 Ϯ 1,010 vs. Ϫ565 Ϯ 646 ms, P ϭ 0.005) during hypoxia ( Fig. 1 and Table 2 ). The magnitude of baroreflex resetting, as determined from the relationship between changes in R-R interval and systolic blood pressure, was significantly related to Ti, but not Vt, during both hypercapnia (r 2 ϭ 0.67, P ϭ 0.007) and hypoxia (r 2 ϭ 0.79, P Ͻ 0.001) (Fig. 2) . Furthermore, correlation analysis of cardiovagal baroreflex gain or set point with hypoxic and hypercapnic ventilatory responses indicated no significant relationships. Sympathetic baroreflex sensitivity was not altered by hypercapnia or hypoxia ( Table 2 , Fig. 3 ).
MSNA data were successfully collected in six subjects during hypercapnia and seven subjects during hypoxia. Compared with baseline, sympathetic burst amplitude was elevated during both hypercapnia (0.18 Ϯ 0.5 mV vs. 0.22 Ϯ 0.9 mV, P ϭ 0.004) and hypoxia (0.21 Ϯ 0.07 mV vs. 0.27 Ϯ 0.11 mV, P ϭ 0.02). MSNA burst frequency increased from 21 Ϯ 9 bursts/min at baseline to 28 Ϯ 7 bursts/min (P ϭ 0.03); however, when normalized to bursts/100 heart beats, no differences in burst probability were observed (Table 1) . Hypercapnia had no effect on MSNA burst frequency, burst incidence, or total MSNA, whereas hypoxia resulted in a significant increase in total MSNA (4.56 Ϯ 3.07 vs. 7.37 Ϯ 3.26 mV/min, P ϭ 0.002). The average size of MSNA bursts was increased in both hypoxia (P ϭ 0.02) and hypercapnia (P ϭ 0.004) relative to baseline (Table 1) .
Our subanalysis of the four participants from which MSNA was obtained during both protocols yielded identical results to those from the larger group, outlined above. These four participants exhibited similar ventilatory responses during hypercapnia (11.5 Ϯ 2.1 to 25.2 Ϯ 4.9 l/min, P Ͻ 0.001) and hypoxia (11.7 Ϯ 3.2 to 28.4 Ϯ 4.7 l/min, P Ͻ 0.001) and an identical increase in MSNA burst amplitude (0.22 Ϯ 0.08 to 0.26 Ϯ 0.08, P Ͻ 0.05; and 0.22 Ϯ 0.06 to 0.26 Ϯ 0.09, P Ͻ 0.05; during hypercapnia and hypoxia, respectively). Similarly, total MSNA was elevated by both hypercapnia (P Ͻ 0.05) and hypoxia (P Ͻ 0.05) with no change in burst probability.
DISCUSSION
In the present study, we have for the first time, to our knowledge, directly compared the effects of systemic hypoxia and hypercapnia on cardiovagal and sympathetic function when the magnitude of chemostimulation was maintained at similar levels. The new findings of this study are first, both hypoxia and hypercapnia caused a downward right shift of the cardiovagal baroreflex set point, whereas hypoxia, but not hypercapnia, caused a reduction in cardiovagal baroreflex gain. Second, the shift in cardiovagal set point was strongly related to inspiratory time during hypoxia or hypercapnia and not VT Table 2 . Set point data correspond only to data used in spontaneous cardiovagal analysis. or chemoreflex ventilatory gain, suggesting that the rate of inspiration or ventilatory acceleration, may be the stimulus for lung stretch receptor feedback mechanisms. Third, both hypoxia and hypercapnia increased sympathetic burst amplitude, whereas hypoxia, but not hypercapnia, also caused an increase in sympathetic burst frequency. However, neither hypercapnia nor hypoxia affected sympathetic burst probability or baroreflex gain. Fourth, compared with hypercapnia, hypoxia caused a greater reduction in total peripheral resistance, a greater increase in heart rate and a trend for a greater cardiac output response. However, peripheral venous pressure remained unchanged during either condition, perhaps indicating altered hemodynamics within the venous circulation. Together these data indicate a differential impact of systemic hypoxia vs. hypercapnia on cardiovagal and sympathetic function. However, these differences were not related to chemosensitivity as expected.
Baseline data. Subjects exhibited no differences in respiratory, cardiovascular, or autonomic variables during the baseline periods prior to hypercapnia and hypoxia. These data demonstrate no carryover effects between conditions. Cardiorespiratory responses. Participants in the present study exhibited hypoxic and hypercapnic ventilatory gains consistent with previous findings (32) . In addition, when the more general, and comparable, measure of inspiratory drive (mean inspiratory flow, VT/Ti) was used (33) , the drive to breathe during hypercapnia and hypoxia was equivalent. This matched our observation of similar increases in minute ventilation during both conditions and achieved our goal of delivering gas stimuli of comparable magnitude, which was driven by increases in VT but not f B .
Cardiovascular gains measured in these participants were also similar to previously reported values (1, 51) . However, unlike ventilation, there was a greater increase in heart rate during hypoxia vs. hypercapnia. The mechanism underlying the different heart rate responses during hypercapnia and hypoxia is not clear. The increase in the circulating chronotropic hormones norepinephrine and epinephrine was similar between the two stimuli. Also, changes in MSNA burst amplitude or burst probability were similar between the two stimuli. Therefore, the different heart rate responses during hypercapnia and hypoxia are not explained by peripheral indices of sympathetic activation. It is possible that the nonuniform distribution of sympathetic nerve activity to different vascular beds in response to various stimuli, as observed in rats (43) , cats (21) , rabbits (31) , and humans (3), is responsible, but this effect Values are expressed as means Ϯ SD. Significant difference from baseline within conditions: *P Ͻ 0.05, †P Ͻ 0.01, ‡P Ͻ 0.001. could not be studied in the present protocol. Also, the direct effect of ventilation on heart rate should have been similar between hypercapnia and hypoxia. It may be that hypercapnia directly impacts heart rate (23) or that hypoxia directly affects pulmonary neural activity, although this effect is only speculation. Beyond these possibilities, it remains reasonable that the decreased gain in cardiovagal baroreflex control, which was only observed during hypoxia, is a major mechanism involved in the altered heart rate control.
Cardiovagal baroreflex control. During both hypercapnia and hypoxia concurrent increases in mean arterial pressure and heart rate (decreased R-R interval) indicated a resetting of the cardiovagal baroreflex set point. However, only hypoxia modified (decreased) the gain of the cardiovagal baroreflex. Our observation of an unchanged cardiovagal baroreflex gain during hypercapnia is supported by the early work of Bristow et al. (6) and, more recently, Simmons et al. (47) . It is, however, at odds with the findings of Cunningham et al. (8) and a later investigation by Bristow et al. (7) . These disparate results may be explained by differences in the magnitude of hypercapnia or hypoxia. In those studies exhibiting a depressed cardiovagal gain, hypercapnia was Ն ϩ10 Torr from baseline, while in studies failing to show a similar depression (including our own) hypercapnia was Յ ϩ 10 Torr from baseline. From these data, it appears that a hypercapnia threshold of ϩ10 Torr from baseline exists below which changes in cardiovagal function are not measurable. As such, the level of hypercapnia in the present study may have been insufficient to realize a depressed cardiovagal baroreflex gain in this population. In contrast, hypoxia caused a marked reduction in cardiovagal gain (ϳ50%) in our participants. Further indicating that a threshold mechanism may be operating, it appears that a hemoglobin saturation of ϳ80% is an important threshold around which cardiovagal gain becomes depressed via a flattening of the baroreflex curve (41) . This explanation is in keeping with our data. A second possibility is that a reflex-mediated increase in heart rate due to a larger total peripheral resistance stimulus (decrease) resulted in a greater heart rate via parasympathetic nervous system withdrawal. The withdrawal of parasympathetic nervous system activity would result in a decreased operating range and, in turn, a decreased baroreflex gain.
In this study, attempts were made to achieve similar total ventilation responses to the two chemoreflex stimuli to reduce the known influence of breathing patterns on autonomic cardiovascular control (15, 25, 56) . For example, parasympathetic control of the heart (i.e., respiratory sinus arrhythmia) (15) varies across the ventilatory cycle and in some (25) , but not all cases (46) , breathing frequency affects sympathetic outflow. Furthermore, increased breathing frequency may decrease cardiovagal baroreflex gain (56) . As well, the tachycardic effects of chemoreceptor stimulation by hypoxia are dependent on the ventilatory response (11) . The colocalization of baroreceptor, chemoreceptor, and lung stretch afferents in the brain stem supports an anatomical basis for this interaction (9, 10, 12) . In this context, chemoreceptor stimulation resulted in an increase in the depth of ventilation, whereby one should expect pulmonary stretch receptors to inhibit vagal nuclei producing an increased heart rate. Interestingly, while we were able to achieve similar changes in V E, VT, and f B during hypercapnia and hypoxia, the change in cardiovagal reflex set point was strongly correlated to changes in inspiratory time. In turn, altered inspiration time was not dependent upon the hypoxia or hypercapnia stimulus but rather was an individualized response to either stimulus such that some participants increased their inspiration time, whereas in others it was reduced. Yet the inverse relationship between Ti and the cardiovagal baroreflex set point remained linear. Thus, it appears that the reflex resetting phenomenon is related to peripheral inputs from the lungs, or from central respiratory centers, relating to ventilatory kinetics rather than chemoreceptor stimulation per se. Neither VT nor drive to breathe (VT/Ti) affected the cardiovagal set point. Therefore, the stimulus for this resetting may be tied to peak, not mean, inspiratory flow occurring during early inspiration.
Sympathetic activation and baroreflex control. Both hypercapnia and hypoxia protocols increased sympathetic activity. However, this sympathoexcitatory response was limited to increases in burst amplitude during hypercapnia, while only hypoxia exhibited increases in both amplitude and burst frequency. Burst amplitude is dependent on electrode position and the number of active sympathetic neurons within the recording range of the electrode. As the number of neurons in an electrode's receptive field is not known, MSNA is often expressed as the number of integrated bursts and/or as a total normalized measure (mean amplitude ϫ frequency) with little information on the specific nature of changes in sympathetic output. In the present study, the size of bursts was also assessed. All nerve recordings were continued into the recovery period and compared against baseline measures. Furthermore, no shift or degradation of the MSNA signal was detected in any recording presented. Thus, we are confident that burst amplitude changes reported here are representative of increased neuronal recruitment.
These changes in sympathetic nerve activity may offer important information on sympathetic control and recruitment strategies during reflex stimulation. A potentially important observation in this study was an increase in burst frequency during hypoxia that was not observed during hypercapnia. This first-level analysis suggests that central discharge of sympathetic neural activity has been modified differently by hypoxia than by hypercapnia. However, similar to the findings of Saito et al. (42) , this difference in sympathetic activity was not evident when expressed as bursts per 100 heart beats, indicating no change in burst probability. Therefore, the augmented tachycardia observed during hypoxia may be one explanation for the differences in burst frequency between hypercapnia and hypoxia. In interpreting the present results, it is important to take into consideration that burst frequency represents one measure of the nervous signal to resistance arteries, whereas bursts per 100 heart beats accounts for central baroreflex gating of sympathetic output. As such, hypoxia resulted in greater peripheral outflow of sympathetic activity compared with hypercapnia, but the central baroreflex control did not appear to be different. This observation is consistent with the finding that sympathetic baroreflex gain was not affected by either hypercapnia or hypoxia. These data, corroborated by the findings of Halliwill and colleagues (18, 19) and Simmons et al. (47) , indicate that the sympathetic baroreflex remains unaltered during chemoreflex activation.
While MSNA levels were increased during both hypoxia and hypercapnia, circulating norepinephrine was not altered by either stimulus. This is consistent with previous findings (40, 54) and is explained by enhanced clearance of norepinephrine by hypoxia (22) . The present findings suggest that chemoreflex stimulation by either hypoxia or hypercapnia leads to the same pattern of enhanced norepinephrine clearance. Nonetheless, circulating epinephrine was increased in both conditions and this may have modulated the systemic vascular response in the presence of elevated neurogenic constrictor activity.
Hemodynamic consequences. With a greater number of sympathetic bursts in hypoxia it is possible that a different cardiovascular effect was induced relative to hypercapnia. As noted above, both hypoxia and hypercapnia resulted in tachycardia but heart rate increased more during hypoxia. Combined with a more pronounced decrease in total peripheral resistance during hypoxia, cardiac output tended to be greater during hypoxia compared with hypercapnia, while peripheral venous pressure remained unchanged. As mechanical factors associated with breathing would be similar between conditions (e.g., the respiratory pump) it is tempting to relate the trend for a greater increase in cardiac output during hypoxia to the sympathetic response of a greater number of bursts per minute in hypoxia vs. hypercapnia. In this interpretation, a continuing fall in systemic resistance with a constant peripheral venous pressure and rising cardiac output does suggests that venous return was augmented. Thus, an additional role of sympathetic activation in these reflexes likely involves blood flow redistribution and the defense of venous return. Whether venous return is maintained through a differential effect of chemoreflex-mediated sympathetic activation toward venous tissue and/or vascular stiffening remains unknown.
Considerations. In the present study, we assessed the differential cardiorespiratory and autonomic responses to systemic hypercapnia and hypoxia. Hypercapnia stimulates both peripheral and central chemoreceptors, whereas hypoxia stimulates primarily peripheral chemoreceptors. Using the present paradigm, we were unable to dissociate the impact of peripheral vs. central chemoreceptor stimulation. However, this was not the goal of the present study.
A second consideration is that the analysis of the cardiovagal baroreflex was not based on the response across a wide range of blood or transluminal carotid sinus pressures. While pharmacologic or mechanical stimulation protocols have the advantage of describing a broad portion of the baroreflex curve, these interventions may also complicate the interpretation of results. Specifically, infusion of vasoactive drugs alters arterial diameter and tone and, in turn, may impact baroreception independent of concurrent pressure changes (26) . On the other hand, neck suction and compression are free of pharmacological limitations, but must be performed while subjects hold their breath (41) , which has been shown to alter the cardiovascular and autonomic responses to chemostimulation in animals (e.g., rats, rabbits, dogs) (11) and humans (11, 25, 44) . Therefore, we assessed spontaneous baroreflex function using the slope method described by Smyth et al. (48) . While this technique only describes a small portion of the baroreflex curve, the similarities between our findings and those of others using invasive pharmacological techniques (6, 47) indicates the usefulness of the slope method as reliable means of measuring the dynamic baroreflex response to chemostimuli. The utility of such a noninvasive method may help further the understanding of vagal function and adaptation over time with prolonged chemostimulation, such as during acclimatization to altitude.
Perspectives and Significance
The data from the present study highlight similarities and differences in reflex autonomic cardiovascular control during hypercapnia and hypoxia. Here we suggest that acute, systemic hypercapnia and hypoxia produce very similar cardiovagal and sympathetic responses when normalized to the same degree of ventilatory stimulation. However, more importantly, these data highlight the potential role of lung-stretch receptors in modifying the cardiovagal response to both hypercapnia and hypoxia. This has implications from methodological planning and interpretation of results to the impact of clinical interventions, such as artificial ventilation and continuous positive airway pressure therapy whereby changes in titrated pressure may affect inspiratory timing and, in turn, cardiovagal control. Furthermore, a simplistic view of ventilatory responses to chemostimulation may miss key concomitant regulation by altered breathing mechanics. In this context, the present data point to new potential areas of interest in the study of sleep apnea and associated cardiovascular morbidity. During apneas, systemic changes in CO 2 and O 2 elicit chemoreflex-mediated autonomic and cardiovascular arousal in the absence of lung inflation. However, as we have shown here, lung stretch receptors play an important role in cardiovascular control during reflex activation. Importantly, the present study also showed that there is no typical response to hypercapnia or hypoxia in terms of the Ti response. Rather, only when subjectspecific responses were considered did the relationship between cardiovagal control and change in Ti become apparent. Thus, the integrated response of chemoreflex activation of the autonomic response is modulated by the manner in which the same stimuli affect the breathing response that, in turn, is modulated differently across individuals.
